HealthTech
Beyond CAR-T: Why Autologous Epigenetic Therapy Represents Cellular Medicine’s Next Chapter
CAR-T’s $2 Million Problem The cellular therapy revolution promised personalized medicine that would fundamentally transform cancer treatment. Six FDA-approved CAR-T products now...
